Illustris Pharmaceuticals
Palo Alto, US · Founded 2016 · Delaware corporation
Find your way into Illustris Pharmaceuticals
Sign up to see every warm intro you have to Illustris Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Illustris Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JL
Jaehoon LeeExecutive
MP
Mark PrygockiExecutive
JM
Jacob M. WaughNamed on SEC filing
Board
SK
Siak Khim TanBoard director
AH
Andrew HirschbergBoard director
JS
Jonah ShacknaiBoard director
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2016
▶$5MraisedMar 2017 · 14 investors · BiotechnologyRule 506(b)
▶$5MraisedMar 2017 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew HirschbergDirector
- Jonah ShacknaiDirector
- Jaehoon LeeExecutive Officer
- Mark PrygockiDirector, Executive Officer
- Jacob M. WaughExecutive Officer, Director
- Siak Khim TanDirector
- Gloria VasquezExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Illustris Pharmaceuticals raised?
- Illustris Pharmaceuticals has disclosed $5M raised across 1 round.
- Where is Illustris Pharmaceuticals headquartered?
- Illustris Pharmaceuticals is headquartered in Palo Alto, US.
